Markets

US stocks slump to lows late in session after reports of fresh semiconductor curbs on China

A listless day for US stocks turned into a bit of a sell-off late in the session after a report that the White House told chip software companies to halt sales to clients in China.

The S&P 500 closed down 0.6%, the Nasdaq 100 gave back 0.5%, and the Russell 2000 fell 1.1%.

Every S&P 500 sector fell outside of real estate, which was flat. Materials and energy were the worst performers.

Cadence and Synopsys slid about 11% on the report regarding chip software design sales to China, while Nvidia erased its pre-earnings gains. On the flip side, Fair Isaac and Warner Bros. Discovery were among the day’s top S&P 500 gainers. Elsewhere…

Abercrombie & Fitch soared as much as 30% after posting strong Q1 results, but the Zillennial-favorite retailer cut its full-year outlook and flagged $50 million in tariff-related costs.

Air taxi maker Joby Aviation also saw its stock surge 28% after announcing a $250 million investment from the world’s largest automaker, Toyota.

Shares of Dick’s Sporting Goods ticked up nearly 2% after the sportswear retailer topped Q1 estimates and reaffirmed its full-year outlook.

Stellantis shares fell 3% after the world’s No. 4 biggest automaker named ex-Jeep boss Antonio Filosa as its new CEO, as sales continue to slow in the US.

Shares of Rocket Lab jumped as much as 5%, before closing largely flat, after Stifel analysts upped their price targets on the stock and competitor SpaceX suffered its latest failure.

More Markets

See all Markets
Oracle Wall Street Revisions

Analysts revise up anything and everything they thought about Oracle

After the company’s bombshell earnings this week, Wall Street thinks Oracle’s trajectory has changed.

markets

Six Flags pops after reiterating its guidance as theme park attendance rebounds

Six Flags shares rose more than 7% today after the company reported a rebound in attendance and early season-pass sales heading into the fall. The nine-week period ending August 31 saw 17.8 million guests, up about 2% from the same stretch in 2024, with stronger momentum in the final four weeks. 

More importantly, Six Flags reaffirmed its full-year adjusted EBITDA guidance of $860 million to $910 million, showing confidence that its cost and operations strategy can stay strong for the duration of the year. Riding that wave, Six Flags also said early 2026 season pass unit sales are pacing ahead of last year, and average season pass prices are up around 3%.

The good vibes come despite a drop in in-park per capita spending, especially from admissions, where promotions and changes to attendance mix (which parks or days guests visit) have weighed. Earlier this week, the amusement giant extended a new agreement that extended its position as the exclusive amusement park partner for Peanuts™ in North America through 2030.

Despite the rally, Six Flags shares are down around 52% year-to-date.

markets

Rivian turns red on the year, squeezed by a recall and the looming end of the EV tax credit

Shares of EV maker Rivian are down more than 5% on Friday following the company’s recall of 24,214 vehicles due to a software issue. The stock move erases Rivian’s year-to-date gain and turns the company negative on the year.

Rivian’s 2025 model year R1S and R1T are affected by the defect, which was identified after a vehicle’s hands-free highway assist software failed to identify another vehicle on the road, causing a low-speed collision. Rivian said it’s released an over-the-air update to fix the issue.

The recall marks Rivian’s fifth this year, affecting nearly 70,000 of its vehicles.

Rivian’s shares are down more than 20% from their 2025 high, which came prior to the passage of President Trump’sbig, beautiful bill.” Through the legislation, the $7,500 EV tax credit is set to expire at the end of the month.

markets

Moderna, Pfizer dip after WaPo reports Trump officials’ plan to link Covid vaccines to child deaths

Vaccine makers are falling after The Washington Post reported that the Trump administration plans to link the coronavirus vaccine to 25 child deaths.

Moderna and Pfizer, the two companies who sell the vaccine in the US, fell by more than 5% and 2%, respectively. The coronavirus vaccine is virtually the only revenue driver for Moderna, while Pfizer has a larger and more diverse portfolio.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.